Using the canine microbiome to bridge translation of cancer immunotherapy from pre-clinical murine models to human clinical trials is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01 CA224166-01, R03CA252793, T32CA251007
NCI NIH HHS
Grant: R03 CA252793
NCI NIH HHS
Grant: T32 CA251007
NCI NIH HHS
Grant: U01 CA224166
National Institutes of Health
Grant: 5T32CA251007-03
UC Davis Comparative Oncology Training Program
National Institutes of Health
Grant: 1U01CA224166-01
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
National Institutes of Health
Grant: 5R03CA252793-02
Gene Expression Analysis of Dog Natural Killer Cells as Immunotherapy Target
FWCI
1.25
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals